Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations
Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations Millennium: The Takeda Oncology Company today reported on data from oral presentations of VELCADEĀ® (bortezomib) for Injection based therapy in multiple myeloma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). These data highlight VELCADE based therapy ...